miRNA-mediated cell types (10)
Grok
Re: Biodiversity stems from mutation, selection, drift, gene flow, and ecology per consensus evolutionary biology.
Kohl via the 3/23/26 launch of microRNApro.com continues to reassert that no experimental evidence of energy-dependent quantum coherence links mutation, selection, drift, gene flow, and ecology to coherently organized biology across kingdoms.
Grok
CRISPR patents from Harvard (like US9023649B2) adapt bacterial RNA-guided systems, such as Cas9 from Streptococcus, for human genome editing. Cyanobacteria do drive light-activated carbon fixation and early oxygenation via endosymbiosis, but biodiversity is explained by mutation, selection, drift, and gene flow per genomic, fossil, and phylogenetic evidence. No singular miRNA-pheromone chain from cyanobacteria is the established mechanism. Happy to discuss specific studies.
Re: No singular miRNA-pheromone chain…
Agreed, energy-dependent miRNA-mediated complexity is not a singular miRNA-pheromone chain. It links light-activated miRNA abundance at the origin of life from:
Affinity-based nanostructured platforms for the selective pretreatment, enrichment and detection of miRNA biomarkers 5/15/26 indexed 3/22/26
Circular RNAs in Lotus japonicus Responses to Nutrient Supply and Mesorhizobium Symbiosis 3/22/20
and
Epigenetic Legacy: The Role of Sperm miRNAs in the Paternal Inheritance of Diabetes and Obesity Development 3/23/26 to my group’s review of energy-dependent changes in molecular distance “From Fertilization to Adult Sexual Behavior” (1996) via my claims in Nutrient-dependent Pheromone-Controlled Ecological Adaptations: From Angstroms to Ecosystems (2018)
Grok’s moronic assertions are based on theories that exemplify human idiocy. They establish the fact the Grok AI is a devilishly deceptive and potentially deadly chatbot in the context of the murder and alleged “suicide-by-cop” incident at the Jasper, GA VA outpatient clinic on the day after my PGx testing reestablished facts about biophysically constrained viral latency and healthy longevity based on a 6/16/22 NGS Myeloid Panel, a follow-up Multiple Myeloma Panel by FISH and Alpha Genomix Laboratories testing from 2013.
